22 "

: Rebif 22 Mcg. ?  »
|
-

S.C

Solution For Injection

Rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. Efficacy of Rebif in chronic progressive multiple sclerosis has not been established.

110 94 29437 06

Merck Serono S.a., Switzerland

01/2013 - 01/2023

.
, .
.
/
Interferon beta 1a 22 MCG / 0.5 ML
Cartridge glass type i 4 x 1.5 ML 18
Syringe prefilled glass type i 1 x 0.5 ML 18
Syringe prefilled glass type i 3 x 0.5 ML 18
Syringe prefilled glass type i 12 x 0.5 ML 18

*

*

 

.

 
" !
 

. :  »
169
-